GBM AGILE Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM (GCAR-7213)

Clinical Trial Grant

Duke Scholars

Principal Investigator Katherine Barnett Peters Neurosurgery, Neuro-Oncology

Co-Principal Investigator Mustafa Khasraw Neurosurgery

Administered By

Duke Cancer Institute

Awarded By

Global Coalition

Start Date

September 27, 2021

End Date

December 31, 2025

Administered By

Duke Cancer Institute

Awarded By

Global Coalition

Start Date

September 27, 2021

End Date

December 31, 2025